2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Stomach Cancer
Stomach cancer, medically known as gastric cancer, poses a significant global health challenge, particularly in regions with high rates of infection by the bacterium Helicobacter pylori. Research in this field focuses on various fronts. One key area is the development of early detection methods, such as biomarker identification and advanced imaging techniques, to diagnose the disease in its initial stages when treatment is most effective. Additionally, scientists explore novel treatment modalities, including targeted therapies and immunotherapies, to improve patient outcomes and reduce adverse effects associated with traditional treatments like chemotherapy and surgery. Moreover, understanding the genetic and molecular mechanisms underlying stomach cancer helps in personalized medicine approaches, tailoring treatments to individual patients' specific tumor characteristics. Collaborative efforts between researchers, clinicians, and pharmaceutical companies drive progress in combating this formidable disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China